Sirinil Rattanachart, Wongteerasut Anundorn
Department of Pediatrics, Phramongkutklao Hospital and Phramongkutklao College of Medicine, Bangkok, Thailand.
Clin Exp Pediatr. 2025 Aug;68(8):587-593. doi: 10.3345/cep.2024.01795. Epub 2025 Mar 11.
Functional gastrointestinal disorders (FGIDs) are associated with various gastrointestinal (GI) and non-GI symptoms, risk factors for which commonly include psychosocial and physical stresses.
This study aimed to compare somatic symptom severity between children with FGIDs and healthy controls during acute illnesses.
This was a prospective descriptive cross-sectional study whose inclusion criterion was age 4-18 years. Children were classified into FGID and control groups using the Rome IV diagnostic criteria. Somatic symptom severity was estimated using a visual analogue scale (VAS) and the Children's Somatic Symptoms Inventory-24 (CSSI-24) questionnaire and compared between groups.
Ninety-three children, including 40 with FGIDs (43%), were enrolled. The FGID group had statistically significantly higher VAS scores for abdominal pain than controls (2.93±3.68 vs. 0.72±2.08, P<0.001). However, no significant intergroup differences were noted in VAS scores for nausea (P=0.493) or headache (P=0.311). For somatization symptoms, the CSSI-24 total (20.58±18.32 vs. 7.06±10.49, P<0.001), GI symptom (9.60±7.48 vs. 2.43±3.39, P≤0.001) and non-GI symptom (10.98±11.67 vs. 4.62±7.88, P< 0.001) scores were significantly higher for the FGID versus control groups, respectively.
Children with FGIDs exhibited more significant somatic symptoms than controls during acute illnesses. GI and non-GI manifestations were significantly more common in children with FGIDs.
功能性胃肠疾病(FGIDs)与各种胃肠道(GI)和非胃肠道症状相关,其风险因素通常包括心理社会和身体压力。
本研究旨在比较FGIDs患儿与健康对照在急性疾病期间的躯体症状严重程度。
这是一项前瞻性描述性横断面研究,纳入标准为年龄4至18岁。根据罗马IV诊断标准将儿童分为FGID组和对照组。使用视觉模拟量表(VAS)和儿童躯体症状量表-24(CSSI-24)问卷评估躯体症状严重程度,并在组间进行比较。
共纳入93名儿童,其中40名患有FGIDs(43%)。FGID组腹痛的VAS评分在统计学上显著高于对照组(2.93±3.68对0.72±2.08,P<0.001)。然而,恶心(P=0.493)或头痛(P=0.311)的VAS评分在组间未观察到显著差异。对于躯体化症状,FGID组的CSSI-24总分(20.58±18.32对7.06±10.49,P<0.001)、胃肠道症状(9.60±7.48对2.43±3.39,P≤0.001)和非胃肠道症状(10.98±11.67对4.62±7.88,P<0.001)评分分别显著高于对照组。
FGIDs患儿在急性疾病期间比对照组表现出更显著的躯体症状。FGIDs患儿的胃肠道和非胃肠道表现明显更常见。